Orthogonal polarisation spectral imaging as a new tool for the assessment of antivascular tumour treatment in vivo: a validation study

por Pahernik, S, Harris, A G, Schmitt-Sody, M, Krasnici, S, Goetz, A E, Dellian, M, Messmer, K
Publicado 2002

The Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI): grading disease severity and assessing responsiveness to clinical change in epidermolysis bullosa

por Jain, S.V., Harris, A.G., Su, J.C., Orchard, D., Warren, L.J., McManus, H., Murrell, D.F.
Publicado 2016

Abaloparatide-SC improves trabecular microarchitecture as assessed by trabecular bone score (TBS): a 24-week randomized clinical trial

por Bilezikian, J. P., Hattersley, G., Fitzpatrick, L. A., Harris, A. G., Shevroja, E., Banks, K., Leder, B. Z., Zanchetta, J. R., Hans, D.
Publicado 2017

The reliability and validity of outcome measures for atopic dermatitis in patients with pigmented skin: A grey area()()

por Zhao, C.Y., Wijayanti, A., Doria, M.C., Harris, A.G., Jain, S.V., Legaspi, K.N., Dlova, N.C., Law, M.G., Murrell, D.F.
Publicado 2015

Foot care in epidermolysis bullosa: evidence‐based guideline

por Khan, M.T., O'Sullivan, M., Faitli, B., Mellerio, J.E., Fawkes, R., Wood, M., Hubbard, L.D., Harris, A.G., Iacobaccio, L., Vlahovic, T., James, L., Brains, L., Fitzpatrick, M., Mayre‐Chilton, K.
Publicado 2019